Albenatide

艾本那肽

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameAlbenatide
Drug Alias NameAlbenatidum阿贝那肽AlbenatidaPC-DAC™:Exendin-4PC-DAC +[8] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesConjuChem Biotechnologies Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHebei Changshan Biochemical Pharmaceutical Co LtdChangshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co Ltd
Inactive CompaniesConjuchem Inc
Active IndicationsOverweightObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A